221
Views
27
CrossRef citations to date
0
Altmetric
Review

Current management of parainfluenza pneumonitis in immunocompromised patients: a review

Pages 121-127 | Published online: 08 Aug 2012

Figures & data

Figure 1 Schematic of the parainfluenza virion.

© 2005, American Society for Clinical Investigation. Reproduced with permission from Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115(7):1688–1698.

Abbreviation: HN, Hemagglutinin-neuraminidase protein.

Figure 1 Schematic of the parainfluenza virion.© 2005, American Society for Clinical Investigation. Reproduced with permission from Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115(7):1688–1698.Abbreviation: HN, Hemagglutinin-neuraminidase protein.

Figure 2 Schematic illustration of the parainfluenza life cycle.

© 2005, American Society for Clinical Investigation. Reproduced with permission from Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115(7):1688–1698.

Abbreviation: RER, rough endoplasmic reticulum; HPIV, human parainfluenza virus; L, large RNA polymerase protein; M, matrix protein; NP, nucleocapsid protein; P, phosphoprotein.

Figure 2 Schematic illustration of the parainfluenza life cycle.© 2005, American Society for Clinical Investigation. Reproduced with permission from Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest. 2005;115(7):1688–1698.Abbreviation: RER, rough endoplasmic reticulum; HPIV, human parainfluenza virus; L, large RNA polymerase protein; M, matrix protein; NP, nucleocapsid protein; P, phosphoprotein.

Table 1 Reports of ribavirin treatment of PIV infection in HSCT patients

Figure 3 Percent mortality broken down by treatment group and presence or absence of co-pathogens.

Figure © 2001, American Society for Blood and Marrow Transplantation. Adapted with permission from Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant. 2001;7 Suppl:11S–15S.Citation22

Abbreviation: IVIG, intravenous gammaglobulin.

Figure 3 Percent mortality broken down by treatment group and presence or absence of co-pathogens.Figure © 2001, American Society for Blood and Marrow Transplantation. Adapted with permission from Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant. 2001;7 Suppl:11S–15S.Citation22Abbreviation: IVIG, intravenous gammaglobulin.